CD14 and metabolic dysfunction-associated steatohepatitis: Enhanced expression of leptin-induced hepatic CD14 may increase hepatic responsiveness to even low levels of gut microbiota-derived endotoxins, which may prompt the progression of simple steatosis to NASH via STAT3 signaling.